Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program

Award Number: R50CA288382
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/16/2024
PERIOD OF PERFORMANCE END DATE: 08/31/2029

Group Awards By:

View Award Description

Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program - This Clinician Scientist project is proposed by Elie Dib, MD, MS, FACP, a member of the Michigan Cancer Research Consortium (MCRC)-National Community Oncology Research Program. MCRC is well established and based at the Trinity Health Ann Arbor (THAA) Hospital, which is a small academic medical center, associated with the nation’s fifth largest health system. Dr. Dib practices as a medical oncologist within THAA and Chelsea Hospital, a joint venture with Michigan Medicine. Over 40 trial sites and 140 investigators conduct research as part of MCRC. Dr. Dib concurrently serves as Adjunct Faculty Lecturer at Johns Hopkins University, teaching in the areas of Cancer Biology and Therapeutics and Individualized Genomics and Health. Dr. Dib has been a highly productive MCRC co-I since 2016, contributing the following major deliverables: a) site PI for over 60 protocols enrolling 800 patients across MCRC; b) enrolling investigator for 200+ patients completing NCI trials; c) co-founder and Vice Chair of Alliance Immuno-Oncology Committee; d) community co-chair of seven Alliance trials and representative to the NCI iMATCH initiative. He is also serving a 3-year term with the NCI Genitourinary Cancers Steering Committee. Aims of the project will be to continue established and successful clinical trials activities and gain protected research time to complete the following: a) contribute to newly-funded MCRC initiatives aimed at increasing the rate of clinical trials enrollment at all MCRC locations; b) launch safety lead-in work and more Phase I trials at MCRC’s most capable sites; c) evaluate and help adopt AI and PROs tool(s) for improving efficiencies in research such as patient screening and building capacity to use real-world evidence; d) continue collaboration development within MCRC community sites, that are joint ventures with Michigan Medicine, to bring a wider range of NCI-funded studies to community settings. In completing this work, Dr. Dib will provide essential knowledge, skills, and abilities as a community-based oncologist to NCI clinical trials initiatives. This project fills a gap for NCI by bringing a highly-qualified community oncologist into the Clinician Scientist program. Nationally, most oncology care is delivered in the community, often in tandem with high-functioning clinical trials programs. Thus, his perspective and experience represents the broader cancer care community. His work will have high impact for all of MCRC, Alliance, NCI, and the large population of patients and families who access cancer care outside of major academic medical centers.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $113,202 )
2025	2025	TRINITY HEALTH-MICHIGAN	5301 E HURON RIVER DR	YPSILANTI	MI	48197	WASHTENAW	USA	Cancer Treatment Research	000	2	8/18/2025	NON-COMPETING CONTINUATION	$113,202
														Subtotal = $113,202

Issue Date FY: 2024 ( Subtotal = $113,202 )
2024	2024	TRINITY HEALTH-MICHIGAN	5301 E HURON RIVER DR	YPSILANTI	MI	48197	WASHTENAW	USA	Cancer Treatment Research	000	1	9/16/2024	NEW	$113,202
														Subtotal = $113,202

Grand Total All Awards = $226,404

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Research Capacity Building by a Clinician Scientist within the Michigan Cancer Research Consortium- National Community Oncology Research Program

Award Number: R50CA288382

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/16/2024

PERIOD OF PERFORMANCE END DATE: 08/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer